Deals

Venaxis Closes $20M CMPO via Cannaccord, Craig-Hallum

By |

Venaxis Inc (APPY) announced that it has raised $20,004,000 in a CMPO/Overnight transaction. The common stock was sold at $2.40 per share, an approximate 11% discount to the market price ($2.71) of APPY at deal announcement. Canaccord Genuity Inc. acted as Sole Book-Runner with Craig-Hallum Capital Group LLC as Lead Manager on the transaction. Underwriter counsel was Goodwin Procter, LLP and issuer counsel was Ballard Spahr LLP. The transaction is expected to close on 04/08/2014.

Deals

ZaZa Energy Corp. Announces $10M ATM Program via MLV

By |

ZaZa Energy Corporation (ZAZA) announced that it has secured up to $10,000,000 in an ATM (At the Market) transaction with MLV. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Reed Smith and issuer counsel was Sidley Austin. An agreement was reached on March 31, 2014. via PlacementTracker.

Deals

Catalyst Pharmaceutical Partners Closes $25M CMPO via Roth, H.C. Wainwright

By |

Catalyst Pharmaceutical Partners, Inc. (CPRX) announced that it has raised $25,028,250 in a CMPO/Overnight transaction. The common stock was sold at $2.21 per share. Piper Jaffray acted as Sole Book-Running Manager with Roth Capital Partners as Co-Lead Manager and H.C. Wainwright as Co-Manager on the transaction. Underwriter counsel was Goodwin Procter and issuer counsel was Akerman. The transaction is expected to close on April 08, 2014.

Deals

Cytomedix Raises $9M in Conv Debt at 89% Discount from Deerfield Management

By |

Cytomedix, Inc. (CMXI) announced that it has raised $9,000,000 in a Convertible Senior Secured Debentures transaction. The Notes are convertible at the lesser of $0.057 per share, an approximate 88.6% discount to the market price ($0.50) of CMXI at deal announcement and 93% of the last sale on the Date of Closing. BTIG, LLC acted as Placement Agent and the investor was Deerfield Management Company. Note that this Placement funded in two tranches. The first tranche of $9,000,000 funded on 3/31/2014 and the second tranche of $26,000,000 will fund upon shareholder approval.